David Domzalski Vyne Therapeutics Inc. (VYNE) insider trading activity

David Domzalski is PRESIDENT AND CEO of VYNE Therapeutics Inc.. Currently has a direct ownership of 445,563 shares of VYNE, which is worth approximately $833,202. The most recent transaction as insider was on Sep 02, 2021, when has been sold 320,312 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 446K

6.41% 3M change

9.83% 12M change

Total Value Held $833,202

David Domzalski Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 02 2021	BUY Grant, award, or other acquisition	-	320,312 Added 29.22%	775,911 Common Stock
Jun 30 2021	SELL Payment of exercise price or tax liability	$66,195 $3.51 p/Share	18,859 Reduced 3.97%	455,599 Common Stock
May 28 2021	BUY Grant, award, or other acquisition	$3,162 $3.36 p/Share	941 Added 0.2%	474,458 Common Stock
Mar 31 2021	SELL Payment of exercise price or tax liability	$43,201 $6.84 p/Share	6,316 Reduced 1.32%	473,517 Common Stock
Feb 22 2021	BUY Grant, award, or other acquisition	-	153,750 Added 24.27%	479,833 Common Stock
Dec 31 2020	SELL Payment of exercise price or tax liability	$15,256 $1.58 p/Share	9,656 Reduced 0.73%	1,304,334 Common Stock
Nov 30 2020	BUY Grant, award, or other acquisition	$6,181 $1.45 p/Share	4,263 Added 0.32%	1,313,990 Common Stock
Sep 30 2020	SELL Payment of exercise price or tax liability	$10,357 $1.66 p/Share	6,239 Reduced 0.47%	1,309,727 Common Stock

David Domzalski

PRESIDENT AND CEO

Bridgewater, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYNE shares.

Notify only if

Value

Insider Trading

Get notified when an Vyne Therapeutics Inc. insider buys or sells VYNE shares.

Notify only if

Operation

Value

Type

News

Receive news related to VYNE Therapeutics Inc.

Track Activities on VYNE

Account